Managed care and a changing pharmaceutical industry.
نویسنده
چکیده
منابع مشابه
The Pharmaceutical Distribution Industry
1. Distribute a full line of pharmaceutical products and health and beauty aids to chain stores, independent drug stores, hospitals, and other health care facilities. In other words, FoxMeyer’s customers were retailers and dispensers. 2. Provide managed care and information-based services to health care facilities, pharmacies and physicians. 3. Conduct business in franchising variety stores and...
متن کاملReframing the pharmaceutical manufacturer/health plan relationship in managed care.
Managed care is stuck in a vendor stage of health care industry evolution that is organized, primarily, to beat back costs through contracted discounts and utilization management. At the same time, the potential exists for an altogether different managed care that is based on a more explicit mission of lowering costs through improved quality. The foundation for this alternative approach is evid...
متن کامل"Under the radar": nurse practitioner prescribers and pharmaceutical industry promotions.
OBJECTIVE To assess nurse practitioners' interactions with pharmaceutical industry promotional activities and their perception of information reliability and self-reported prescribing behaviors. STUDY DESIGN Self-administered online survey. METHODS A nationally randomized sample of nurse practitioner prescribers was surveyed. Eligibility criteria included current clinical practice and licen...
متن کاملThe view from managed care pharmacy.
This stratified, national telephone survey of fifty-one managed care organizations concerns the perspectives of managed care pharmacy directors on pharmacoeconomics, disease management, and the roles of the pharmaceutical industry and the Food and Drug Administration (FDA). Respondents rated clinical effectiveness assessments as most useful, cost-effectiveness assessments second, and quality-of...
متن کاملRETURNS ON R&D FOR 1990s NEW DRUG INTRODUCTIONS
Previously published research by two of the authors found that returns on R&D for drugs introduced into the market in the 1970s and 1980s were highly skewed and that the top decile of new drugs accounted for close to half the overall market value. In the 1990s, there have been significant changes to the R&D environment for new medicines: the rapid growth of managed care organizations; indicatio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Health affairs
دوره 9 3 شماره
صفحات -
تاریخ انتشار 1990